T2DM, a chronic systematic metabolic disease, is characterized by pancreatic β cells dysfunction and insulin resistance, which are characterized by that insulin is not sensitive to glucose and subsequently develop hyperglycemia and pancreatic β cells loss (Hameed et al., 2015). This evidence concerns the gene INS and Insulin resistance.